Harbour BioMed Appoints Dr. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies

Summary

Harbour BioMed appointed Dr. Bob Zhang as President of its Metabolic Disease Franchise to accelerate global development of innovative therapies. The appointment represents an internal organizational change within the company's therapeutic areas including immunology and oncology.